“Adherence to (or compliance with) a medication regimen is generally defined as the extent to which patients take medications as prescribed by their health care providers.
Prescribed Medications is important part in the treatment of co-occurring disorders. They can reduce symptoms and prevent relapses of a psychiatric disorder. Medications can also help patients minimize cravings and maintain abstinence from addictive substances.
In order to get the most out of medication, patients must make an informed choice about taking medications, and understand the potential benefits and costs associated with medication use. In addition, they must take the medication as prescribed by a mental health professional.
Taking medication is not substance abuse. Some people in recovery for a substance use disorder may think it is wrong to take any medications. However, a medication that manages one’s mood is very different from a drug that alters one’s mood.
Prescription medications have been developed and tested for all of the Axis I psychiatric disorders. Effective medication options exist for the treatment of most of the major disorders, including mood disorders such as major depression and bipolar disorder; anxiety disorders, such as post-traumatic stress disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder; and schizophrenia and other psychotic disorders.
Placebo-controlled trials have demonstrated that medications for mental health disorders reduce or eliminate symptoms. For example, antidepressant medications such as the selective serotonin reuptake inhibitors (SSRIs) consistently reduce symptoms of depression by 30 percent to 60 percent overall and lead to complete remission in a significant proportion of patients. Effective psychotherapies have also been developed and tested for many mental health disorders and can be utilized without medications for patients with mild or moderate disorders. However, medication is an important mainstay of treatment for patients with more severe and/or long-standing mental illness symptoms.
Many patients do not take medication as prescribed. Some simply forget medications, but often “forgetting” is really related to an underlying concern. Prescribers should assume that a patient will sometimes failt to take his or her medications. In these cases, they should ask about the missed medication in a nonjudgmental way. When patients are not adherent to the medication plan, modifications to the medication prescription or to the plan should be based on the patients’ unique reasons for not taking them.
If a patient reports side effects, or changes the way he or she takes medications due to side effects, prescribers should do their best to address the problem. Full empathic attention to the difficulty and reassurance that it will subside is sometimes enough to reduce the concern. Serious side effects or ones that interfere with functioning should be addressed by changing the timing or dose of the medication, by taking the medication with or without food, or by using another medication to alleviate the problem. At times, a medication switch will be required to address non-adherence.
Prescribers should avoid prescribing medications that are known to interact with the patient’s preferred substances of abuse. Psychotropic medications that are safe in the context of substance use should be utilized with the following advice:
“Please take this medication every day, even if you are using substances. The medication won’t help your problem with depression if you don’t take it every day, even after you are feeling better. As we have discussed, your goal is to avoid using substances, but if you do use, take the medication anyway.”
Admonitions to the patient not to use substances because he or she is on a medication often result in the patient using substances and not taking the medication.
Some patients may misattribute mental health disorder symptoms to medication use. A careful documentation of mental health disorder symptoms prior to prescribing medication is helpful in this situation. Patients with psychosis, for example, may say the medication causes hallucinations. Patients with depression and fatigue may attribute the fatigue to the medication. Education and reminders can be helpful, but if a patient is fully convinced that the medication is causing mental health disorder symptoms, switching medications may be an option to address this problem.
Sometimes a patient is willing to take medication as prescribed, but the attitude of a family member interferes. Inquiring about how family and friends perceive the use of medication is important. If a spouse has concerns, it’s vital to include him or her in the educational process. It’s important for clinicians to provide education to all concerned family members. This education should include information about mental health and substance use disorders and their treatment.
While the official stance of Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) is that taking medications prescribed by a medical professional is compatible with recovery, some individuals in peer support groups may still view psychotropic medications as potentially addictive substances that should be avoided by people with addiction or substance use issues. This perception may be due to the fact that benzodiazepines and other tranquilizers, which can indeed be addictive, were commonly prescribed in the past to patients with substance use disorders. Many effective, nonaddictive alternatives to these medications are now available.
Patients may run into particular individuals in peer support groups, or even entire groups, who are not supportive of medication use. It’s important to remind people that medication is one important tool they can use in their own personal recovery path. The patient may want to shop around for other peer support groups that are more supportive of people with co-occurring disorders.
The effects of medication for mental health disorders can take several days to several weeks to take place, and it can take several months for their full effects to be felt by a patient. Once the mental health disorder is stabilized over a period of months, the medication should be continued for approximately six months. Patients with mood and anxiety disorders may consider tapering and discontinuing medication, depending on how chronic and severe the mental health disorder symptoms are. Patients with bipolar disorder and psychotic disorders may benefit from remaining on medication for a much longer period of time, often for life. Reseearch suggests that relapse of symptoms occurs within a year of discontinuation of medication in these types of disorders.
Integrated treatment is now considered an evidence-based practice because multiple randomized controlled trials have shown it to be more effective than other approaches
Administrators and program leaders can evaluate an existing program’s capability to provide integrated services with the Dual Diagnosis Capability in Addiction Treatment Index or the Dual Diagnosis Capability in Mental Health Treatment Index.
Used appropriately as part of a broader assessment, screening tools give clinicians a common language and objective metric. They provide a consistent approach to testing for the presence or absence of a disorder and help patients receive effective treatment.
We’ve collected some of the more commonly used public-domain screening tools. These self-reports are sensitive and research supported. The generic measures cover a broad range of psychiatric or substance use orders while specific measures target a particular disorder.
|Modified Mini Screen
(MMS) — A self-report measure that rapidly assesses for present mood, anxiety, and psychotic-spectrum disorders
Mental Health Screening Form III
CAGE Adapted to Include Drugs
Simple Screening Instrument
|Center for Epidemiologic Studies Depression Scale
(CES-D) — A twenty-item questionnaire about depressive symptoms
Social Interaction Anxiety Scale